Company Filing History:
Years Active: 2015
Title: Alejandra Moure Fernández: Innovator in Pharmaceutical Science
Introduction
Alejandra Moure Fernández is a prominent inventor based in Barcelona, Spain. She has made significant contributions to the field of pharmaceutical science, particularly in the development of compounds that target apoptotic processes. Her innovative work has the potential to impact the treatment of various pathological conditions.
Latest Patents
Alejandra holds a patent for Apaf-1 inhibitor compounds. These derivatives of 2,5-piperazinedione are designed to inhibit apoptotic peptidase activating factor 1 (Apaf-1). This innovation is particularly useful as an active pharmaceutical ingredient for the prophylaxis and/or treatment of conditions associated with increased apoptosis. She has 1 patent to her name.
Career Highlights
Alejandra is currently employed at Laboratorios Salvat, S.A., where she continues to advance her research and development efforts. Her work at this esteemed company has allowed her to explore new therapeutic avenues and contribute to the pharmaceutical industry.
Collaborations
Alejandra has collaborated with notable colleagues, including Ángel Messeguer Peypoch and Daniel González Pinacho. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Alejandra Moure Fernández is a trailblazer in the field of pharmaceutical science, with her innovative work on Apaf-1 inhibitors paving the way for new treatment options. Her contributions are invaluable to the ongoing advancements in medical research and development.